First drug for chronic migraine prevention ∞
A weekly nugget or two of pain science news and ideas for patients and pros, usually 400–1000 words. The blog is the “director’s commentary” on the core content of PainScience.com: a library of major articles and books about common painful problems and popular treatments. See the blog archives or updates for the whole site.
First drug for chronic migraine prevention just approved by EU; it got a greenlight from the FDA in May. It's kind of amazing that this is the first drug specifically for migraine prevention ("we can put a man on the moon …") but better late than never? Some good quality analysis here:
Aimovig’s performance relative to a placebo treatment is not that great; it’s not even twice as effective as placebo … But in the clinic, outside of the rarefied circles of clinical trials, clinicians are excited.